Vericel (VCEL) Cash & Current Investments (2010 - 2026)

Vericel (VCEL) reported Cash & Current Investments of $145.3 million for Q1 2026, up 28.74% on a YoY basis from $112.9 million in Q1 2025, and up 5.71% sequentially from $137.5 million in Q4 2025.

Vericel (VCEL) Cash & Current Investments (2010 - 2026) Analysis & Trends

Vericel (VCEL) has 15 years of Cash & Current Investments data on file, last reported at $145.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments rose 28.74% year-over-year to $145.3 million; the trailing twelve-month figure through Mar 2026 stood at $145.3 million (up 28.74% YoY), and the FY2025 full-year result was $137.5 million, up 61.67% from the prior year.
  • Cash & Current Investments advanced to $145.3 million in Q1 2026, from $137.5 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $145.3 million in Q1 2026 to a low of $70.4 million in Q3 2024.
  • A 5-year average of $106.4 million and a median of $110.6 million in 2024 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments decreased 27.33% in 2023 and jumped 92.43% in 2025, its largest moves.
  • Tracing VCEL's Cash & Current Investments over 5 years: stood at $119.5 million in 2022, then dropped by 27.33% to $86.9 million in 2023, then decreased by 2.09% to $85.0 million in 2024, then soared by 61.67% to $137.5 million in 2025, then advanced by 5.71% to $145.3 million in 2026.
  • Business Quant data shows VCEL's Cash & Current Investments at $145.3 million in Q1 2026, $137.5 million in Q4 2025, and $135.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 68,184.45 Bn 68,184.17 Bn - 283.54 Mn
2 Nanobiotix 1,953.19 Bn 1,953.13 Bn - 61.40 Mn
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn - -
4 BeOne Medicines 474.39 Bn 469.59 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 123.45 Bn 116.21 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 69.92 Bn 61.16 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 63.43 Bn 63.43 Bn - -
8 Argenx Se 56.67 Bn 51.49 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 38.08 Bn 38.08 Bn - -
10 Vericel 2.34 Bn 2.19 Bn 49.27 Mn 145.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 145.35 Mn
Dec 31, 2025 137.50 Mn
Sep 30, 2025 135.38 Mn
Jun 30, 2025 116.85 Mn
Mar 31, 2025 112.90 Mn
Dec 31, 2024 85.05 Mn
Sep 30, 2024 70.35 Mn
Jun 30, 2024 75.85 Mn
Mar 31, 2024 110.65 Mn
Dec 31, 2023 86.87 Mn
Sep 30, 2023 83.56 Mn
Jun 30, 2023 97.83 Mn
Mar 31, 2023 119.28 Mn
Dec 31, 2022 119.54 Mn
Sep 30, 2022 110.94 Mn
Jun 30, 2022 100.69 Mn
Mar 31, 2022 100.55 Mn
Dec 31, 2021 103.40 Mn
Sep 30, 2021 98.29 Mn
Jun 30, 2021 90.98 Mn